These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 11330536

  • 1. High cysteine levels in renal transplant recipients: relationship with hyperhomocysteinemia and 5,10-MTHFR polymorphism.
    Marcucci R, Fedi S, Brunelli T, Pepe G, Prisco D, Rosati A, Zanazzi M, Bertoni E, Abbate R, Salvadori M.
    Transplantation; 2001 Mar 27; 71(6):746-51. PubMed ID: 11330536
    [Abstract] [Full Text] [Related]

  • 2. Effect of MTHFR genotypes and hyperhomocysteinemia on patient and graft survival in kidney transplant recipients.
    Hagen W, Födinger M, Heinz G, Buchmayer H, Hörl WH, Sunder-Plassmann G.
    Kidney Int Suppl; 2001 Feb 27; 78():S253-7. PubMed ID: 11169021
    [Abstract] [Full Text] [Related]

  • 3. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A, Coppola A, Madonna P, Fermo I, Pagano A, Mazzola G, Galli L, Cerbone AM.
    Thromb Haemost; 2000 Apr 27; 83(4):563-70. PubMed ID: 10780318
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for cardiovascular disease in renal transplant recipients: new insights.
    Marcucci R, Zanazzi M, Bertoni E, Brunelli T, Fedi S, Evangelisti L, Pepe G, Rogolino A, Prisco D, Abbate R, Gensini GF, Salvadori M.
    Transpl Int; 2000 Apr 27; 13 Suppl 1():S419-24. PubMed ID: 11112046
    [Abstract] [Full Text] [Related]

  • 5. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
    Födinger M, Wölfl G, Fischer G, Rasoul-Rockenschaub S, Schmid R, Hörl WH, Sunder-Plassmann G.
    Kidney Int; 1999 Mar 27; 55(3):1072-80. PubMed ID: 10027946
    [Abstract] [Full Text] [Related]

  • 6. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort.
    Chango A, Potier De Courcy G, Boisson F, Guilland JC, Barbé F, Perrin MO, Christidès JP, Rabhi K, Pfister M, Galan P, Hercberg S, Nicolas JP.
    Br J Nutr; 2000 Dec 27; 84(6):891-6. PubMed ID: 11177206
    [Abstract] [Full Text] [Related]

  • 7. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.
    de Jong SC, Stehouwer CD, van den Berg M, Kostense PJ, Alders D, Jakobs C, Pals G, Rauwerda JA.
    Arterioscler Thromb Vasc Biol; 1999 May 27; 19(5):1316-24. PubMed ID: 10323785
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J.
    Circulation; 1999 May 11; 99(18):2383-8. PubMed ID: 10318658
    [Abstract] [Full Text] [Related]

  • 10. Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients.
    Ho GY, Eikelboom JW, Hankey GJ, Wong CR, Tan SL, Chan JB, Chen CP.
    Stroke; 2006 Feb 11; 37(2):456-60. PubMed ID: 16397167
    [Abstract] [Full Text] [Related]

  • 11. Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients.
    Födinger M, Buchmayer H, Heinz G, Papagiannopoulos M, Kletzmayr J, Perschl A, Vychytil A, Hörl WH, Sunder-Plassmann G.
    Am J Kidney Dis; 2001 Jul 11; 38(1):77-84. PubMed ID: 11431185
    [Abstract] [Full Text] [Related]

  • 12. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R, Bonnardeaux A, Geadah D, Busque L, Lebrun M, Ouimet D, Leblanc M.
    Kidney Int; 2000 Aug 11; 58(2):851-8. PubMed ID: 10916110
    [Abstract] [Full Text] [Related]

  • 13. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
    Billion S, Tribout B, Cadet E, Queinnec C, Rochette J, Wheatley P, Bataille P.
    Nephrol Dial Transplant; 2002 Mar 11; 17(3):455-61. PubMed ID: 11865092
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
    Hyndman ME, Manns BJ, Snyder FF, Bridge PJ, Scott-Douglas NW, Fung E, Parsons HG.
    Metabolism; 2003 Feb 11; 52(2):168-72. PubMed ID: 12601627
    [Abstract] [Full Text] [Related]

  • 16. Effect of MTHFR 1298A-->C and MTHFR 677C-->T genotypes on total homocysteine, folate, and vitamin B(12) plasma concentrations in kdiney graft recipients.
    Födinger M, Buchmayer H, Heinz G, Papagiannopoulos M, Kletzmayr J, Rasoul-Rockenschaub S, Hörl WH, Sunder-Plassmann G.
    J Am Soc Nephrol; 2000 Oct 11; 11(10):1918-1925. PubMed ID: 11004224
    [Abstract] [Full Text] [Related]

  • 17. Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients.
    Bostom AG, Gohh RY, Tsai MY, Hopkins-Garcia BJ, Nadeau MR, Bianchi LA, Jacques PF, Rosenberg IH, Selhub J.
    Arterioscler Thromb Vasc Biol; 1997 Oct 11; 17(10):1894-900. PubMed ID: 9351351
    [Abstract] [Full Text] [Related]

  • 18. An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease.
    Wrone EM, Zehnder JL, Hornberger JM, McCann LM, Coplon NS, Fortmann SP.
    Kidney Int; 2001 Sep 11; 60(3):1106-13. PubMed ID: 11532106
    [Abstract] [Full Text] [Related]

  • 19. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
    Achour O, Elmtaoua S, Zellama D, Omezzine A, Moussa A, Rejeb J, Boumaiza I, Bouacida L, Rejeb NB, Achour A, Bouslama A.
    J Nephrol; 2016 Oct 11; 29(5):691-8. PubMed ID: 26559681
    [Abstract] [Full Text] [Related]

  • 20. Hyperhomocysteinemia in stable pediatric, adolescents, and young adult renal transplant recipients.
    Krmar RT, Ferraris JR, Ramirez JA, Galarza CR, Waisman G, Janson JJ, Llapur CJ, Sorroche P, Legal S, Cámera MI.
    Transplantation; 2001 Jun 27; 71(12):1748-51. PubMed ID: 11455253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.